Liechtenstein Blockchain Innovator LCX Announces It Will Work With Wesley Snipes To Tokenize $25 Million USD Movie Fund

LCX announced today that it has entered a partnership with Dr. Wesley Snipes to tokenize a $25 Million USD movie fund, investing in upcoming motion picture and television shows produced by the famous actor and his production studio Maandi House. This will be the first time enabling movie enthusiasts to invest alongside Hollywood icons and producers. The goal is to launch a fully regulated tokenized security via LCX’s platform and Liechtenstein based blockchain infrastructure. The security token offering will lower the barrier of entry significantly allowing a broader audience of institutional and retail investors to tap into this opportunity.

The $25 Million USD Daywalker Movie Fund (DMF) will be tokenized and represented by the DMF Security Token. The fund will be managed by an investment committee consisting of professional fund managers and Dr. Snipes. The movie fund will allocate production budgets to future motion picture productions alongside other Hollywood producers.

LCX’s blockchain technology platform will handle the registration and identification of investors and will serve as the central hub for the security token offering.

The DMF Token enables investors to benefit from the profits of the productions and the IP, and receive additional benefits, including the opportunity to be invited to the movie premiere events. Profits are reinvested in the value of the DMF token, to ensure sustainable long-term value creation.

Wesley Snipes added, "It’s an exciting time now that all of my fans old and new, can indirectly become co-producers of our upcoming movies. The tokenized Daywalker Movie Fund enables the audience to turn into investors and participate in the success.”

LCX CEO Monty C. M. Metzger said, “The introduction of blockchain technology can be compared to the introduction of email. Tokenization empowers a new class of digital assets and is re-defining the financial industry. Since months the team at LCX has been preparing the partnership including evaluation of regulatory and legal aspects - and we are excited to share this finally in public.”

Pre-registration is possible at LCX.com. Registered users will be prioritized as soon as the security token offering will be officially published.

About Wesley Snipes

Dr. Wesley Trent Snipes is an American actor, film producer, master martial artist, and author. His prominent film roles include New Jack City, Major League, White Men Can't Jump, Passenger 57, Demolition Man, and the Marvel Comics character Blade in the Blade film trilogy. At the Toronto Film Festival TIFF 2019 the Eddie Murphy movie “Dolemite Is My Name” premiered featuring Snipes, who will team again with Murphy and an All Star cast in the sequel to his 90’s classic “Coming To America”.

About LCX

LCX, the Liechtenstein Cryptoassets Exchange, is a blockchain ecosystem for professional investors. LCX’s goal is to become one of the world’s first licensed and supervised blockchain banks seamlessly blending traditional and crypto assets. Founded in 2018, LCX is headquartered in Liechtenstein, a country known for its groundbreaking blockchain laws and being a financial hub with a AAA rating at Standard & Poor's.

The initial product is LCX Terminal, an advanced crypto trading desk to trade on all major crypto exchanges within a single interface. At LCX Assets the fast-growing technology startup is planning a compliant security token platform for issuing, storing and trading of cryptocurrencies, tokenized securities and digital assets - after necessary regulatory approval has been obtained. LCX is a proud member of the World Economic Forum's Centre for the Fourth Industrial Revolution. The advisory board of LCX includes leading experts, such as Don Tapscott (Author Blockchain Revolution), Jimmy Wales (Founder Wikipedia), Frank Gessner (Serial Entrepreneur) and others.

source: businesswire.com

Legal disclaimer: The insight, recommendations and analysis presented here are based on corporate filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. They are presented for the purposes of general information only, and all the information belongs to the original publishers. These may contain errors and we make no promises as to the accuracy or usefulness of the information we present. You should not make any investment decision based solely on what you read here.